Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2002
03/20/2002CN1341124A Anti-CD3 immunotoxins and therapeutic use thereof
03/20/2002CN1341123A Novel G protein-coupled receptor protein and DNA thereof
03/20/2002CN1341122A Covalently bridged insulin dimers
03/20/2002CN1341121A Expression and export of anti-obesity proteins as Fc fusion proteins
03/20/2002CN1341120A 骨刺激因子 Bone stimulator
03/20/2002CN1341029A Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomas
03/20/2002CN1341027A Inhibitors for use in hemostasis and immune function
03/20/2002CN1340629A Method for using human CRYGS gene and its coded products to diagnose and treat lesion of crystalline lens
03/20/2002CN1340549A Process for preparing glucagon
03/20/2002CN1340548A Decontamination and application of human recombined cartilage oligo-substrate protein
03/20/2002CN1340547A Polypeptide-human eukaryotic initiation factor-2 (eIF-2)-associated protein 74.14 and polynucleotide for coding it
03/20/2002CN1340546A Polypeptide-human zinc finger protein 45.87 and polynucleotide for coding it
03/20/2002CN1340545A Polypeptide-human mammary gland susceptible gene coded protein 68.42 and polynucleotide for coding it
03/20/2002CN1340544A Polypeptide-human macroprotein 10.23 and polynucleotide for coding it
03/20/2002CN1340543A Polypeptide-human cell wither associated protein 13.31 and polynucleotide for coding it
03/20/2002CN1340542A Polypeptide-human transcription binding factor gamma subunit (CBF-C) 13.42 and polynucleotide for coding it
03/20/2002CN1340541A Polypeptide-humn Dnaj protein 14.85 and polynucleotide for coding it
03/20/2002CN1340540A Polypeptide-human syntenin protein 38.28 and polynucleotide for coding it
03/20/2002CN1340539A Polypeptide-clathrin light chain 49.5 and polynucleotide for coding it
03/20/2002CN1340538A Polypeptide-ribosomal protein S18-9.46 and polynucleotide for coding it
03/20/2002CN1340537A Polypeptide-human cyclophilin-40-13.2 and polynucleotide for coding it
03/20/2002CN1340536A Polypeptide-human glutamate receptor action protein 33.77 and polynucleotide for coding it
03/20/2002CN1340535A Polypeptide-human macroprotein 12.10 and polynucleotide for coding it
03/20/2002CN1340534A Polypeptide-human caudal action protein 17.38 and polynucleotide for coding it
03/20/2002CN1340533A Polypeptide-dihydrofolate reductase 25.19 and polynucleotide for coding it
03/20/2002CN1340532A Polypeptide-human erythrocyte kytoplasm protein 11 and polynucleotide for coding it
03/20/2002CN1340531A Polypeptide-human golgin-84 protein 11.88 and polynucleotide for coding it
03/20/2002CN1340530A Polypeptide-human macroprotein 10.34 and polynucleotide for coding it
03/20/2002CN1340529A Polypeptide-human shear factor 14.63 and polynucleotide for coding it
03/20/2002CN1340528A Polypeptide-human transcription control factor ZFM1 isomer 12.54 and polynucleotide for coding it
03/20/2002CN1340527A Polypeptide-lymphocyte activator protein 33 and polynucleotide for coding it
03/20/2002CN1340526A Polypeptide-proteasome HC2 subunit 64.57 and polynucleotide for coding it
03/20/2002CN1340525A Polypeptide-human snRNP auxilin Sm 13.64 and polynucleotide for coding it
03/20/2002CN1340524A Polypeptide-human cytochrome bcl compound core protein II 12.21 and polynucleotide for coding it
03/20/2002CN1340523A Polypeptide-human cell wither associated protein 11.44 and polynucleotide for coding it
03/20/2002CN1340522A Polypeptide-human mitochondrial translation initiation factor 20.90 and polynucleotide for coding it
03/20/2002CN1340521A Polypeptide-mechanocyte tropomyosin TM30p112.1 and polynucleotide for coding it
03/20/2002CN1340520A Polypeptide-polyadenylate bindin 33.11 and polynucleotide for coding it
03/20/2002CN1340519A Polypeptide-human cap binding protein 14.08 and polynucleotide for coding it
03/20/2002CN1340518A Polypeptide-human clustering and elongating protein 9.13 and polynucleotide for coding it
03/20/2002CN1340517A Polypeptide-human nucleotide excision repair protein 13.75 and polynucleotide for coding it
03/20/2002CN1340516A Polypeptide-abnormal human cDNA (B120) 14.63 containing CAG repetitive sequence and polynucleotide for coding it
03/20/2002CN1340515A Polypeptide-protein 39.16 containing SH3 structure domain and polynucleotide for coding it
03/20/2002CN1340514A Polypeptide-human U4/U6 small nuclear RNA bindin (U4/U6 snRNP) 13.09 and polynucleotide for coding it
03/20/2002CN1340513A Polypeptide-human cyclophilin-40-14.63 and polynucleotide for coding it
03/20/2002CN1340512A Polypeptide-Pax protein 12.10 and polynucleotide for coding it
03/20/2002CN1340511A Polypeptide-human neuronectin 29.81 and polynucleotide for coding it
03/20/2002CN1340510A Polypeptide-human cytokine receptor 11.88 and polynucleotide for coding it
03/20/2002CN1340509A Polypeptide-human brain macroprotein 9.68 and polynucleotide for coding it
03/19/2002USRE37596 Hybridoma cell line which produces the monoclonal antibody bw sclc-1 having the deposit number ecacc no. 90022110.
03/19/2002US6359198 Nucleotide sequences for use in generating disease resistant and durable plants
03/19/2002US6359197 Regulatory sequences for use in delaying leaf aging in plants
03/19/2002US6359196 Regulatory sequences for generating genetic engineered plants for use in malting and steeping
03/19/2002US6359194 Compositions and methods for the treatment and diagnosis of cardiovascular disease
03/19/2002US6359193 Nucleotide sequences of lats genes
03/19/2002US6359126 Antibodies to αvβ3 integrin
03/19/2002US6359125 Process for preparing peptide nucleic acid probe using polymeric photoacid generator
03/19/2002US6359123 H-rev107-like protein
03/19/2002US6359118 Carbohydrate crosslinked glycoprotein crystals
03/19/2002US6359117 Lymphocyte controlling polypeptide; for use in the treatment of allergies, hodgkins's disease and lung defects
03/19/2002US6359116 Compounds
03/19/2002US6359115 Human receptor tyrosine kinase, KDR
03/19/2002US6359113 Using fused ring system containing at least 4 aromatic rings, and group containing at least one carbon atom which is capable of bonding to a group to be protected; synthesis, separation
03/19/2002US6359112 Peptides used as agonists and/or inhibitors of amyloid formation and cytotoxicity and also for use in alzheimer's disease, in type II diabetes mellitus and in spongiform encephalophathies
03/19/2002US6358931 Oligonucletide conjugated to imidazole; intercalation and coordination compounds; medical diagnosis, gene therapy; antisense agents
03/19/2002US6358927 Peptide fragments and analogs derived from PBAN 1-33 NH2 for controlling moths
03/19/2002US6358923 Preventing and diagnosing blood, genetic, and nervous system disorders associated with decreased genetic expression
03/19/2002US6358920 Nonapeptide anticarcinogenic and antimetastasis agents
03/19/2002US6358918 Administering heat treated, nitrosated proteins selected from albumin, orosomucoid, tissue plasminogen activator, fibrinogen, lys-plasminogen, and/or hemoglobin to humans to improve perfusion and microcirculation
03/19/2002US6358916 Biological activity of IGF-I E domain peptide
03/19/2002US6358915 Administering uteroglobin as anticarcinogenic or antitumor agent to treat breast, lung or prostate cancer
03/19/2002US6358744 Stabilized human papillomavirus formulations
03/19/2002US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects
03/19/2002US6358737 Osteocyte cell lines
03/19/2002US6358734 Compounds for treatment of infectious and immune system disorders and methods for their use
03/19/2002US6358732 Nucleotide sequences preferential polypeptides for use in the treatment of defects in central nervous system
03/19/2002US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections
03/19/2002US6358719 Genes for the biosynthesis of epothilones
03/19/2002US6358711 Generating polyclonal antibody; immunize animal, isolate animal antibodies, screen isolated antibodies with the polypeptide and detect binding of polyclonal antibody
03/19/2002US6358709 End selection in directed evolution
03/19/2002US6358708 Nucleotide sequence coding segment of enzymatic polypeptide; for use in treatment and prevention of fungal infections; fungicides
03/19/2002US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects
03/19/2002US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis
03/19/2002US6358705 Method of making proteins in transformed yeast cells
03/19/2002US6358704 M protein
03/19/2002US6358703 Expression system for factor VIII
03/19/2002US6358702 Polynucleotides encoding human Hox C10
03/19/2002US6358701 A dna molecule encoding a protein; screening agonists and antagonsits; to determining channel modulators that may have insecticidal, mitacidal and/or nematocidal activity
03/19/2002US6358695 Determining compounds that activate or inhibit a g-protein receptor by exposing cells expressing the polypeptide on the surface with a test compound to allow binding and detect a signal in response to binding of agent to the polypeptide
03/19/2002US6358694 Culturing prostaglandin receptor expressing cells in the presence of a test compound; measure the modulating affects of the compound that interacts with the recombinant receptor and compare the affects with a control host cell
03/19/2002US6358693 AMPA-binding human gluR4 receptor methods
03/19/2002US6358512 Feline infectious peritonitis vaccine
03/19/2002US6358511 Inhibitors of HIV infection
03/19/2002US6358510 ICAM-1 derivatives with altered ability to bind LFA-1
03/19/2002US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors
03/19/2002US6358508 Antibodies to human tumor necrosis factor receptor TR9
03/19/2002US6358505 G-CSF receptor agonists
03/19/2002US6358491 Somatostatin analogs
03/19/2002US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures
03/19/2002CA2319966A1 Improved dextran-hemoglobin conjugate as potential blood substitute